Ligand Efficiency
Ligand efficiency metrics quantify how effectively a molecule uses its size to achieve binding potency. These are key metrics in lead optimization, helping medicinal chemists prioritize compounds that are potent relative to their molecular size and lipophilicity.
Metrics
Ligand Efficiency (LE)
Formula: LE = pActivity / N_HA
Where:
- pActivity = −log₁₀(IC₅₀ or Kd in molar)
- N_HA = number of heavy (non-hydrogen) atoms
| LE Value | Interpretation |
|---|---|
| ≥ 0.3 | Efficient — acceptable for drug-like leads |
| 0.2–0.3 | Moderate — may benefit from optimization |
| < 0.2 | Inefficient — consider fragment-based starting points |
When no experimental activity data is available, ChemAudit uses the QED (Quantitative Estimate of Drug-likeness) score as a proxy pIC50 value. The response indicates when a proxy was used via the proxy_used field.
Lipophilic Ligand Efficiency (LLE)
Formula: LLE = pActivity − LogP
LLE (also known as LipE) separates potency from lipophilicity. A high LLE indicates that binding potency is driven by specific molecular interactions rather than non-specific hydrophobic binding.
| LLE Value | Interpretation |
|---|---|
| ≥ 5 | Excellent — potency is not driven by lipophilicity |
| 3–5 | Good — reasonable balance of potency and lipophilicity |
| < 3 | Potency may be primarily driven by lipophilicity |
Why It Matters
During lead optimization, molecular weight and lipophilicity tend to increase ("molecular obesity"). Tracking LE and LLE helps:
- Prioritize efficient leads: Compounds with high LE use fewer atoms to achieve the same potency
- Avoid lipophilicity traps: High LLE compounds are less likely to have off-target effects or poor ADMET properties
- Guide SAR decisions: When adding substituents, check whether LE is maintained or declining
API Usage
Request ligand efficiency as part of the scoring endpoint:
curl -X POST http://localhost:8001/api/v1/score \
-H "Content-Type: application/json" \
-d '{
"molecule": "c1ccc(cc1)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F",
"include": ["ligand_efficiency"]
}'
Response:
{
"molecule_info": { "..." : "..." },
"ligand_efficiency": {
"le": 0.28,
"heavy_atom_count": 27,
"activity_value": 7.5,
"activity_type": "pIC50",
"proxy_used": true
},
"execution_time_ms": 12
}
| Field | Type | Description |
|---|---|---|
le | float | Ligand Efficiency value |
heavy_atom_count | int | Number of heavy atoms |
activity_value | float | pIC50 value (real or proxy) |
activity_type | string | Activity type used |
proxy_used | bool | Whether QED was used as a proxy |
References
- Hopkins, A. L., Groom, C. R. & Alex, A. (2004). Ligand efficiency: a useful metric for lead selection. Drug Discovery Today, 9(10), 430–431.
- Leeson, P. D. & Springthorpe, B. (2007). The influence of drug-like concepts on decision-making in medicinal chemistry. Nature Reviews Drug Discovery, 6(11), 881–890.
Next Steps
- Bioavailability Radar — Oral bioavailability prediction
- Drug-Likeness — Lipinski, QED, and consensus scoring
- ADMET — Absorption, distribution, metabolism, excretion predictions